Clinical Study of Coronary Extension Catheter (NCT07742345) | Clinical Trial Compass
RecruitingNot Applicable
Clinical Study of Coronary Extension Catheter
China69 participantsStarted 2026-06-25
Plain-language summary
This prospective, multicenter, single-arm study plans to enroll 69 subjects. Subjects meeting the protocol criteria will receive treatment with coronary extension catheters. The safety and efficacy of these catheters in percutaneous coronary intervention will be assessed through the collection and analysis of efficacy and safety endpoints during treatment and follow-up.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥18 years, regardless of gender;
* Patients suitable for percutaneous coronary intervention (PCI) and for whom the use of an extension catheter is planned to assist the intervention;
* Ability to understand the purpose of the study, willingness to voluntarily participate, and ability to provide written informed consent.
Exclusion Criteria:
* Reference vessel diameter \< 2 mm;
* Presence of thrombus in the target vessel;
* Unprotected left main coronary artery disease;
* Acute myocardial infarction occurring within 7 days prior to enrollment;
* Known intolerance to anticoagulant or antiplatelet therapy, or known allergy to contrast media;
* Concurrent severe hepatic or renal disease, or other severe systemic conditions that render the patient unsuitable for PCI;
* Pregnant or lactating women;
* Currently participating in another clinical trial of a drug or medical device without having reached the primary endpoint or completed the trial;
* Any other condition that, in the investigator's opinion, makes the patient ineligible for participation in this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.